Gastroenterology strain | Constipation
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
10 billion CFU
FUNCTIONALITY
Constipation • Intestinal transit
Scientific support
Human clinical trial
Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly (BL03, LP01, BS01, LR05, BA02 and BR03 seperately). CIBUS, 2005; 1(1):23-30.
In vitro studies
a) Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice (LA02, LPC00, LP01, LR04, BR03, BL03 and BA02). J Clin Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008.
b) Rossi M. et al. fermentation of fructooligosaccharides and inulin by Bifidobacteria: a comparative study of pure and fecal cultures (BA02). Applied and Environmental Microbiology, 2005;71(10):6150-6158.
Urology strain | Kidney stones
Characteristics
FUNCTIONALITY
Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Scientific support
In vitro studies
Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
Gut-brain blend | Encephalomyelitis
- Lactobacillus rhamnosus – GG (ATCC 53103)
- Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)
- Bifidobacterium breve – BR03 (DSM 16604)
- Bifidobacterium longum – BL03 (DSM 16603)
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
GG 25 billion CFU + BS01 15 billion CFU + BR03 5 billion CFU + BL03 5 billion CFU
FUNCTIONALITY
Sleep improvement and cognitive symptoms improvement in patients with encephalomyelitis/chronic fatigue syndrome
Scientific support
Human clinical trial
Wallis A. et al. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis / chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med 2018, 16:24.
